Medipharm Labs Corp T.LABS

CBD

[Danno13]

You’re invited to a live briefing today at 4:30 pm ET featuring leading voices on the need for Congress to regulate CBD products as dietary supplements.

The briefing will feature an authoritative, in-depth discussion on the current status of CBD and the best path forward, followed by a Q&A with audience questions.

Panelists from the Coalition for Access Now, U.S. Pain Foundation and Balanced Veterans Network will speak to the beneficial role that CBD plays in the lives of millions of Americans from all walks of life. Panelists from ToxStrategies LLC and Dentons will discuss key scientific and legal considerations for future FDA regulation of CBD products as dietary supplements. 

The panelists, who will have just come from meetings on Capitol Hill, include:

• Jennifer Baxter, Executive Director, Balanced Veterans Network
• Kelly Fair, Strategic Advisor, ONE HEMP and US Cannabis and Hemp Group Partner, Dentons
• Paige Figi, Executive Director, Coalition for Access Now
• Nicole Hemmenway, CEO, U.S. Pain Foundation
• Dr. Rayetta Henderson, Foods & Consumer Products, Senior Managing Scientist, ToxStrategies LLC

Register here to watch the briefing live (or to receive a recording).

The opportunity has arrived for substantive federal CBD policy reform in Congress. The ONE HEMP briefing is part of a broader effort to urge the committees of jurisdiction in Congress – House Energy and Commerce and Senate HELP – to move ahead with marking up legislation. Hemp and CBD producers, and the millions of Americans who rely on their products, will all benefit from a clear regulatory framework for CBD products.

About ONE HEMP: With an unwavering commitment to science and consumer safety, ONE HEMP is an industry coalition comprised of respected voices and CBD market leaders whose concerted efforts are aimed at equipping Congress and the FDA with the knowledge and support required to pass sensible guidelines for a standardized CBD industry. Learn more at www.onehemp.org.